Sun, Feb 1, 2015, 12:09 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • johnpapas893 johnpapas893 Aug 17, 2013 10:42 AM Flag

    Genzyme-Sanofi deal

    1. Genzyme's price was $49.86 when on July 2, 2010 Bloomberg reported Sanofi's interest.
    2. On Aug. 29 Sanofi made a bid of $69--a 38.4% premium.
    3. On Oct. 4 Sanofi went hostile at the same price.
    4. In February 16, 2011 Sanofi bought Genzyme for $74 (a 48.4% premium over the July 2 price) plus a CVR of up to $14/share depending on the performance iof Genzyme's experimental MS drug Lemtrada and production levels of two other productrs.

    On June 28, Onyx's price was $86.82. Amgen reportedly offered $120--a 38.2% premium, almost exactly the same as that offered initially by Sanofi. If you apply Sanofi's final premium of 48.8% to Onyx's June 28 price, you get 128.84--pretty close to Amgen's rumored $130 sweetened price. The only thing that is missing is a CVR.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
124.700.0000(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.